Moscow. KAZINFORM All volunteers inoculated with the new coronavirus vaccine evolved through the State Center for Vector Virology and Biotechnology Research are in health, no side effects have been reported.
Clinical trials are expected to be completed in September, the Federal Consumer Rights and Human Welfare Surveillance Service’s press service reported on Friday.
“All inoculated volunteers feel good. To date, the first vaccine has been given to 57 volunteers, while 43 have won a placebo. Six volunteers noticed pain at the injection site. The pain was negligible and short-lived (1-2 days). No side effects were observed in volunteers,” it reads, TASS reports.
The firm added that the EpiVacCorona vaccine produces an immune reaction after double management with a period of 14 to 21 days. To date, a volunteer has been inoculated twice. “Clinical trials are expected to be completed by September 2020,” the fitness control agency concluded.
On August 11, Russia became the first country in the world to sign a vaccine opposed to coronavirus called Sputnik V.La preparation was developed through the Gamaleya National Research Institute in Epidemiology and Microbiology of the Russian Ministry of Health and conducted clinical trials. June-July. Array Is based on a platform known in the past that was used for other vaccines. On 15 August, the Ministry of Health announced the launch of the vaccine production.